Exelixis Appoints Dana T. Aftab, Ph.D. as Executive Vice President of Research and Development
Position
Executive Vice President of Research and Development
Company
Exelixis
AlamedaBiotechnologyHealth CareTherapeuticsresearchDescription
Exelixis, Inc has appointed Dana T Aftab, PhD, as its Executive Vice President of Research and Development. In this role, he will oversee all aspects of the company’s drug discovery and development activities.
Quick answer
Exelixis Appoints Dana T. Aftab, Ph.D. as Executive Vice President of Research and Development (August 29, 2025). Exelixis is based in Alameda, California, United States.
- Who is the new Executive Vice President of Research and Development at Exelixis?
- Exelixis named Dana T. Aftab Executive Vice President of Research and Development, announced August 29, 2025.
- What did Exelixis announce on August 29, 2025?
- Exelixis, Inc has appointed Dana T Aftab, PhD, as its Executive Vice President of Research and Development. In this role, he will oversee all aspects of the company’s drug discovery and development activities.
- What does Exelixis do?
- Exelixis is a globally ambitious oncology company innovating next-generation medicines and regimens at the forefront of cancer care.
- Where is Exelixis based?
- Exelixis is based in Alameda, California, United States.
- Which similar companies made leadership changes around the same time?
- Applied StemCell (August 21, 2025), Rezolute (August 20, 2025), Nuvig Therapeutics (September 9, 2025) and Cantargia AB (August 18, 2025) also announced leadership changes within 45 days of Exelixis.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and research
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Applied StemCell Appoints Dolores Baksh, Ph.D. as Chief Executive Officer (August 21, 2025)
- Rezolute Appoints Sunil Karnawat as Chief Commercial Officer (August 20, 2025)
- Nuvig Therapeutics Appoints David J. Woodhouse as Chief Executive Officer (September 9, 2025)
- Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer (August 18, 2025)
- Legend Biotech Appoints Carlos Santos as Chief Financial Officer (August 18, 2025)
- Altimmune Appoints Linda M. Richardson as Chief Commercial Officer (September 15, 2025)
Who to call at Exelixis, and when
A new leader at Exelixis brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Exelixis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Exelixis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exelixis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exelixis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Exelixis changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.